Oncology - Side Effects News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer

Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage

Smartest Doc Challenge
MDLinx
Melanoma Clinical Pearls

MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools

MDLinx Top Read
MDLinx
Running from that pile of unread journals?

New!	>> Find out who is the Smartest Doc in Oncology!

Articles

Latest Full Text Articles (84) Focus on Bone

Ranked, sorted, and summarized by MDLinx editors from the latest literature

Topics:

21 Predictors of recovery of ovarian function during aromatase inhibitor therapy Annals of Oncology, May 6, 2013 Clinical Article

22 Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases International Journal of Cancer, May 6, 2013 Clinical Article

23 The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy Supportive Care in Cancer, May 6, 2013 Clinical Article

24 Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia Journal of Clinical Oncology, May 3, 2013 Clinical Article

25 Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer Cancer, May 3, 2013 Clinical Article

26 Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers Supportive Care in Cancer, May 3, 2013 Clinical Article

27 Cisplatin-induced Ototoxicity in Pediatric Solid Tumors: The Role of Glutathione S-Transferases and Megalin Genetic Polymorphisms Journal of Pediatric Hematology/Oncology, May 2, 2013 Clinical Article

28 Impact of Chemotherapy-Induced Peripheral Neuropathy on Treatment Delivery in Nonmetastatic Breast Cancer Journal of Oncology Practice, May 2, 2013 Clinical Article

29 Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation Hematological Oncology, May 1, 2013 Clinical Article

30 Development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia Hematological Oncology, May 1, 2013 Clinical Article

31 Late-onset hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation in patients with advanced leukemia: differences in ATG dosage are key International Journal of Hematology, May 1, 2013 Clinical Article

32 Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials International Journal of Clinical Oncology, April 30, 2013 Evidence Based Medicine Clinical Article

33 Cerebral Venous Sinus Thrombosis in Pediatric Cancer Patients: Long-term Neurological Outcomes Journal of Pediatric Hematology/Oncology, April 30, 2013 Clinical Article

34 Brain and Neck Tumors Among Physicians Performing Interventional Procedures The American Journal of Cardiology, April 29, 2013 Clinical Article

35 Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer Cancer Chemotherapy and Pharmacology, April 29, 2013 Clinical Article

36 Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma Full Text BMC Cancer, April 29, 2013

37 The Correlation Between Dose of Folinic Acid and Neurotoxicity in Children and Adolescents Treated for Osteosarcoma With High-dose Methotrexate (HDMTX): A Neuropsychological and Psychosocial Study Journal of Pediatric Hematology/Oncology, April 29, 2013 Clinical Article

38 A predictive model for dysphagia following IMRT for head and neck cancer: Introduction of the EMLasso technique Radiotherapy & Oncology, April 26, 2013 Clinical Article

39 Protective effect of intraoperative nerve monitoring against recurrent laryngeal nerve injury during re-exploration of the thyroid Full Text World Journal of Surgical Oncology, April 26, 2013 Review Article Clinical Article

40 Effect of induction chemotherapy on estimated risk of radiation pneumonitis in bulky non-small cell lung cancer Medical Dosimetry, April 26, 2013 Clinical Article

50 available pages First Previous 2 3 4 5 6 7 8 9 10 11 Next Last

Clinical Pearls in Oncology

The ZORO study demonstrated that the addition of goserelin to neoadjuvant chemotherapy for early breast cancer in premenopausal women resulted in no change in post-chemotherapy rates of amenorrhea
A little over 50% of tumors in women with ER-positive, node-negative breast cancers will have a RS <18, and current data suggests that these women are UNLIKELY to receive a benefit from adjuvant chemotherapy
In patients with completely resected ER-positive DCIS when the surgical specimen also has LCIS, consider breast MRI screening in addition to mammography due to the lower sensitivity of mammograms for lobular disease

» Test your knowledge. Take the Smartest Doc challenge today!

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

1 Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients The Oncologist, April 15, 2013 Free full text

2 Malignant Pericardial Effusion Cardiology, April 8, 2013

3 Enalapril And Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients with Malignant Hemopathies. The OVERCOME Trial JACC - Journal of the American College of Cardiology, April 12, 2013

4 Cardiac Magnetic Resonance Imaging in the Evaluation of the Late Effects of Anthracyclines Among Long-Term Survivors of Childhood Cancer JACC - Journal of the American College of Cardiology, April 5, 2013

5 Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy Journal of the National Cancer Institute, April 18, 2013

6 Bevacizumab and central nervous system (CNS) hemorrhage Cancer Chemotherapy and Pharmacology, April 9, 2013

7 Biomolecular markers of cancer-associated thromboembolism Critical Reviews in Oncology/Hematology, April 2, 2013

8 Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: A multi institutional study Gynecologic Oncology, April 24, 2013

9 Brain and Neck Tumors Among Physicians Performing Interventional Procedures The American Journal of Cardiology, April 29, 2013

10 Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice? Central European Journal of Medicine, April 23, 2013

11 A predictive model for dysphagia following IMRT for head and neck cancer: Introduction of the EMLasso technique Radiotherapy & Oncology, April 26, 2013

12 The Correlation Between Dose of Folinic Acid and Neurotoxicity in Children and Adolescents Treated for Osteosarcoma With High-dose Methotrexate (HDMTX): A Neuropsychological and Psychosocial Study Journal of Pediatric Hematology/Oncology, April 29, 2013

13 Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib Journal of Gastrointestinal Oncology, April 25, 2013 Free full text

14 Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer European Journal of Oncology Nursing , April 23, 2013

15 Venous thromboembolism in adults treated for acute lymphoblastic leukaemia: Effect of fresh frozen plasma supplementation Thrombosis and Haemostasis, April 23, 2013

16 Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index Journal of Clinical Oncology, April 1, 2013

17 Single-dose Palonosetron and Dose-reduced Regimen of Dexamethasone in Preventing Nausea and Vomiting by Anthracycline-including Chemotherapy in Patients with Early Breast Cancer Anticancer Research, April 10, 2013

18 Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV Supportive Care in Cancer, April 3, 2013

19 The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer BMC Cancer, April 5, 2013 Free full text

20 Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia Cancer Chemotherapy and Pharmacology, April 10, 2013

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Oncology - Side Effects News & Articles

Articles

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

HCC risk increased in patients with AIDS

RAB25 is a prognostic marker for ovarian cancer

Most Popular Oncology Articles

Other Topics in Oncology